(Q41395911)

30 September 2017

title

Gene-targeted inhibition of transactivation of human immunodeficiency virus type-1 (HIV-1)-LTR by antisense oligonucleotides (English)

1 reference

30 September 2017

I Demirhan

1

1 reference

30 September 2017

O Hasselmayer

2

1 reference

30 September 2017

D Hofmann

3

1 reference

30 September 2017

A Chandra

4

1 reference

30 September 2017

F P Svinarchuk

5

1 reference

30 September 2017

V V Vlassov

6

1 reference

30 September 2017

J Engels

7

1 reference

30 September 2017

P Chandra

8

1 reference

30 September 2017

publication date

1 January 1995

1 reference

30 September 2017

1 reference

30 September 2017

volume

9

1 reference

30 September 2017

issue

2

1 reference

30 September 2017

page(s)

113-119

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01702654

30 September 2017

exact match

0 references

cites work

Episome-generated N-myc antisense RNA restricts the differentiation potential of primitive neuroectodermal cell lines

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01702654

Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus

21 January 2018

1 reference

12 December 2020

Characterization of a cDNA clone encoding the visna virus transactivating protein

1 reference

12 December 2020

Gene therapy for cancer

1 reference

12 December 2020

Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus

1 reference

12 December 2020

Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides

1 reference

12 December 2020

Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element

1 reference

12 December 2020

Trans-activating rev protein of the human immunodeficiency virus 1 interacts directly and specifically with its target RNA.

1 reference

12 December 2020

Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues

1 reference

12 December 2020

Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation

1 reference

12 December 2020

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

1 reference

12 December 2020

The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice

1 reference

12 December 2020

Induction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer element

1 reference

12 December 2020

Abasic oligodeoxyribonucleoside phosphorothioates: synthesis and evaluation as anti-HIV-1 agents

1 reference

12 December 2020

In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription

1 reference

12 December 2020

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

1 reference

12 December 2020

Selective inhibition of the cytopathic effect of type A influenza viruses by oligodeoxynucleotides covalently linked to an intercalating agent

1 reference

12 December 2020

cis-diamminedichloroplatinum(II)-resistant sublines derived from two human ovarian tumor cell lines

1 reference

12 December 2020

D-Penicillamine inhibits transactivation of human immunodeficiency virus type-1 (HIV-1) LTR by transactivator protein

1 reference

12 December 2020

Inhibition of vesicular stomatitis virus protein synthesis and infection by sequence-specific oligodeoxyribonucleoside methylphosphonates

1 reference

12 December 2020

Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture

1 reference

12 December 2020

Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist

1 reference

12 December 2020

Novel features of retroviruses associated with human diseases

1 reference

12 December 2020

Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Biochemical aspects

1 reference

12 December 2020

Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

1 reference

12 December 2020

Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications

1 reference

12 December 2020

Mechanism of action of regulatory proteins encoded by complex retroviruses

1 reference

12 December 2020

Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4

1 reference

12 December 2020

A nuclear translational block imposed by the HIV-1 U3 region is relieved by the Tat-TAR interaction

1 reference

12 December 2020

Inhibition of human immunodeficiency virus type 1-mediated cytopathic effects by poly(L-lysine)-conjugated synthetic antisense oligodeoxyribonucleotides

1 reference

12 December 2020

Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site

1 reference

12 December 2020

Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

1 reference

12 December 2020

Inhibition of simian virus 40 DNA replication in CV-1 cells by an oligodeoxynucleotide covalently linked to an intercalating agent

1 reference

12 December 2020

Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide

1 reference

12 December 2020

Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells

1 reference

12 December 2020

Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients

1 reference

12 December 2020

Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides

1 reference

12 December 2020

Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3'-terminus and their interaction with DNA within mammalian cells

1 reference

12 December 2020

Phosphoroselenoate oligodeoxynucleotides: synthesis, physico-chemical characterization, anti-sense inhibitory properties and anti-HIV activity

1 reference

12 December 2020

Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense Oligodeoxynucleotides

1 reference

12 December 2020

Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cells proliferation

1 reference

12 December 2020

Complementary-addressed (sequence-specific) modification of nucleic acids

1 reference

12 December 2020

Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.

1 reference

12 December 2020

Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates

1 reference

12 December 2020

Inhibition of human immunodeficiency virus by using an oligonucleoside methylphosphonate targeted to the tat-3 gene.

1 reference

12 December 2020

Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.

1 reference

12 December 2020

Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01702654

1 reference

Dimensions Publication ID

30 September 2017

1046092124

0 references

1 reference